<DOC>
<DOCNO>
EP-0002065
</DOCNO>
<TEXT>
<DATE>
19790530
</DATE>
<IPC-CLASSIFICATIONS>
A01N-33/26 C07C-243/18 A61P-31/00 C07D-327/06 C07D-233/80 C07D-213/77 A61K-31/195 C07C-243/22 C07D-213/00 C07D-215/28 C07D-327/00 C07D-215/42 A01N-33/00 C07D-215/00 C07C-67/00 C07C-243/14 A61K-31/215 A61P-31/10 C07D-295/22 C07C-243/00 A61P-31/04 C07D-233/00 C07D-295/00 A61K-31/185 C07C-241/00 A61P-31/12 C07D-295/30 A61K-31/15 A61K-31/21 
</IPC-CLASSIFICATIONS>
<TITLE>
methyladamantyl hydrazines, their pharmaceutically acceptable salts and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
teva pharmail<sep>teva pharmaceutical industries limited<sep>teva pharmaceutical industries limited har hotzvim behind sanhedria ha'murhevetjerusalemil <sep>
</APPLICANT>
<INVENTOR>
sterling jeffreyil<sep>suchi raulil<sep>weiner ben-zionil<sep>yellin haimil<sep>sterling, jeffrey<sep>suchi, raul<sep>weiner, ben-zion<sep>yellin, haim<sep>sterling, jeffrey126/14 maalot dafna streetjerusalemil<sep>suchi, raul10/2, giladi streetjerusalemil<sep>weiner, ben-zion1, mevo livna streetjerusalemil<sep>yellin, haim46, hurgin streetramat ganil<sep>
</INVENTOR>
<ABSTRACT>
the invention provides novel 1- or 2-adamantylmethyl  hydrazines of the general formula a  in this formula ad is 1- or 2-adamantyl, r₁ and r₂ are  the same or different and are each hydrogen or a lower unsubstituted  or substituted alkyl group of 1-4 carbon atoms;  r₃ and r₄ are the same or different and are each hydrogen,  an unsubstituted or substituted radical being a lower alkyl  group of 1-4 carbon atoms, a lower alkanoic acid radical of  2-4 carbon atoms or a lower alkyl ester thereof, adamantyl,  aryl, aralkyl in which the alkyl moiety has 1-4 carbon atoms  or an unsubstituted or substituted heterocyclic radical of  aromatic character; or r₃ and r₄ together with the nitrogen  atom to which they are attached form a cyclic radical of  non-aromatic character.  the invention further provides pharmaceutically  acceptable acid addition salts of the above compounds.  several methods of preparation of the new compounds  are described.  the novel compounds according to the invention  possess valuable antifungal (human and plant), antiviral,  antiprotozoal and antimicrobial properties.  
</ABSTRACT>
</TEXT>
</DOC>
